By far, one of the leading producers of molecular quality control standards and controls for labs that provide clinical diagnostic and blood testing, is AcroMetrix.

AcroMetrix’s range of products include controls and standards that assist in the implementation and monitoring of diagnostic assays and the company recently announced the release of their new panel, the OptiQuant-S HCV RNA Qualification. This new panel gives labs a critical component to help them better optimize their assays for Hepatitis C.

AcroMetrix’s Internet-based solutions and quality control products make it much easier for laboratories to validate new assays, train their technicians and set standards for creating notable quality control programs.

The President and CEO of AcroMetrix, Michael Eck, is quoted as saying, “OptiQuant-S HCV represents our continued commitment to Hepatitis C diagnostic testing. Medical laboratories utilizing the new OptiQuant-S HCV Panel will experience the benefits of a standardized product that offers consistent results with an enhanced dynamic range; and as a result reducing patient re-testing requirements and increasing savings in both labor and reagent costs.”

The primary aspect that makes OptiQuant so special is the inclusion of AcroMetrix’s proprietary technology called SynTuraâ„¢. This technology involves second generation viral RNA material that acts much like enveloped mammalian RNA viruses like HIV and HCV.

SynTuraâ„¢ allows researchers to insert synthetic sequences into mammalian RNA viruses that demonstrate stability in replication and are capable of forming infectious RNase resistant virus particles. With this system, labs can design defined RNA positive controls, quantify standards and create better internal controls and calibrations.

The impact of this new technology could prove to be huge in the medical community as more than 75% of all liver disease cases in the world can be attributed to viral Hepatitis B and C. Since physicians routinely monitor 1 HCV patients to keep tabs on the amount of virus in their systems, having accurate viral load test results are important when determining treatment and drug therapies. The OptiQuant-S HCV RNA Qualification Panel will help ensure this accuracy.

To learn more about OptiQuant and AcroMetrix’s other products, go to their website at www.acrometrix.com.

Additional Resources

AcroMetrix :: Homepage

AcroMetrix :: Article on Uploads.biz

AcroMetrix :: Listed on DownTownProfile.com

AcroMetrix :: Information on 1HRO.com

AcroMetrix :: Article on CorporationReview

AcroMetrix :: Article on DTProfile.com